The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 972,770 | 465,440 | SH | SOLE | 465,440 | 0 | 0 | |||
| ALLOVIR INC | COM | 019818103 | 9,056,817 | 11,202,000 | SH | SOLE | 11,202,000 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 2,368,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 86,721,303 | 3,006,980 | SH | SOLE | 3,006,980 | 0 | 0 | |||
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | 46,445,095 | 1,976,387 | SH | SOLE | 1,976,387 | 0 | 0 | |||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 638,880 | 176,000 | SH | SOLE | 176,000 | 0 | 0 | |||
| BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 2,583,900 | 594,000 | SH | SOLE | 594,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 14,053,920 | 552,000 | SH | SOLE | 552,000 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 32,172,711 | 2,012,052 | SH | SOLE | 2,012,052 | 0 | 0 | |||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 1,140,271 | 666,825 | SH | SOLE | 666,825 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 14,094,000 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | |||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 23,002,450 | 1,115,000 | SH | SOLE | 1,115,000 | 0 | 0 | |||
| CYBIN INC | COM | 23256X407 | 4,352,508 | 489,596 | SH | SOLE | 489,596 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 47,823,742 | 1,746,667 | SH | SOLE | 1,746,667 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 9,437,118 | 262,726 | SH | SOLE | 262,726 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 8,737,089 | 1,093,503 | SH | SOLE | 1,093,503 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 9,062,928 | 9,187,883 | SH | SOLE | 9,187,883 | 0 | 0 | |||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 2,612,475 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 18,250,000 | 250,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 31,887,860 | 436,820 | SH | SOLE | 436,820 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,874,880 | 992,000 | SH | SOLE | 992,000 | 0 | 0 | |||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 17,172,420 | 3,018,000 | SH | SOLE | 3,018,000 | 0 | 0 | |||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 7,266,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
| NEUROGENE INC | COM | 64135M105 | 629,400 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| NKARTA INC | COM | 65487U108 | 542,400 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| NUVATION BIO INC | COM CL A | 67080N101 | 27,872,765 | 12,171,513 | SH | SOLE | 12,171,513 | 0 | 0 | |||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 715,249 | 312,336 | SH | SOLE | 312,336 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 21,097,500 | 2,425,000 | SH | SOLE | 2,425,000 | 0 | 0 | |||
| PEPGEN INC | COM | 713317105 | 3,215,800 | 376,117 | SH | SOLE | 376,117 | 0 | 0 | |||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 18,986,690 | 1,422,224 | SH | SOLE | 1,422,224 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 11,491,104 | 620,470 | SH | SOLE | 620,470 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 7,480,200 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 586,920 | 292,000 | SH | SOLE | 292,000 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 6,694,011 | 4,263,701 | SH | SOLE | 4,263,701 | 0 | 0 | |||
| RENEO PHARMACEUTICALS INC | COM | 75974E103 | 3,825,000 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 52,580,220 | 1,198,000 | SH | SOLE | 1,198,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 9,190,166 | 4,572,222 | SH | SOLE | 4,572,222 | 0 | 0 | |||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 4,972,066 | 2,576,200 | SH | SOLE | 2,576,200 | 0 | 0 | |||
| UNICYCIVE THERAPEUTICS INC | COM | 90466Y103 | 3,491,216 | 8,559,000 | SH | SOLE | 8,559,000 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 5,212,629 | 2,391,114 | SH | SOLE | 2,391,114 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 52,798,704 | 1,835,200 | SH | SOLE | 1,835,200 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 19,792,500 | 870,000 | SH | SOLE | 870,000 | 0 | 0 | |||